dactinomycin and Hemangioma Thrombocytopenia Syndrome

dactinomycin has been researched along with Hemangioma Thrombocytopenia Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fuchimoto, Y; Hirobe, S; Kamagata, S; Kumagai, M; Kuroda, T; Matsuoka, K; Morikawa, N; Morikawa, Y	1

Other Studies

1 other study(ies) available for dactinomycin and Hemangioma Thrombocytopenia Syndrome

Article	Year
Vincristine, actinomycin D, cyclophosphamide chemotherapy resolves Kasabach-Merritt syndrome resistant to conventional therapies. Pediatrics international : official journal of the Japan Pediatric Society, 2012, Volume: 54, Issue:2 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Hemangioendothelioma; Humans; Infant, Newborn; Kasabach-Merritt Syndrome; Male; Platelet Count; Sarcoma, Kaposi; Treatment Failure; Vincristine	2012

Article

Year

Vincristine, actinomycin D, cyclophosphamide chemotherapy resolves Kasabach-Merritt syndrome resistant to conventional therapies.

Pediatrics international : official journal of the Japan Pediatric Society, 2012, Volume: 54, Issue:2

Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Hemangioendothelioma; Humans; Infant, Newborn; Kasabach-Merritt Syndrome; Male; Platelet Count; Sarcoma, Kaposi; Treatment Failure; Vincristine

2012